Rev 10/11/2026 · Master Clinical Training Suite

DLP 19: Natalie Cruz

Complete Clinical Lifecycle: Patient Portal Registration, Dermal Filler Vascular Disclosure Screening (AES-FILLER-REVERSAL-READINESS), Arrival Clock Reset, Check-In Safety Clearance, Visible Rooming, Clinical Intake Vitals, Restylane L Micro-Cannula Midface Contouring, and Square Terminal POS Checkout.

Scenario 19 AES-FILLER-REVERSAL-READINESS Dr. Colette Marchand, MD Square Terminal POS ($800.00) 100% Pass Validated
Interactive Scene Jump Points
Click any chapter to seek directly to that clinical milestone

Clinical Safety Governance

Scenario Code: DLP-SCR-19

Governing Rule: AES-FILLER-REVERSAL-READINESS (Dermal filler planned without vascular disclosure)

Clinical Protocol: When a patient requests dermal filler contouring during portal intake, the engine triggers an automatic front-desk safety alert requiring documented vascular risk disclosure, aspiration protocol affirmation, and on-site hyaluronidase reversal kit verification.

Patient & Provider Demographics

Patient Persona: Natalie Cruz (Male, DOB: 1990-05-15, Age 36)

Address: 3300 S Broadway, Edmond, OK 73013

Phone: (405) 555-0119 | SSN Last 4: 4018

Attending Clinician: Dr. Colette Marchand, MD

Clinical Coordinator: Sarah Jenkins | Clinical Assistant: Alex Morgan, PA-C

Documented Treatment & Settlement

Primary Treatment: Restylane L 1.0mL with Micro-Cannula Technique (1 syringe, $800.00)

Adjunctive Service: Comprehensive Aesthetic Consultation & Evaluation ($0.00)

Tender Method: Square Terminal POS Device (In-Person)

Transaction Settlement: Approved #TX-73034-POS | Balance Due: $0.00

Audit Invariant: Patient card retained in Lane 12 (Completed) for statutory census reconciliation.